| Mrs Allison Marie Curtis, NP | |
|
65 N Madison Ave, Suite 800, Pasadena, CA 91101-2035 | |
| (626) 792-3141 | |
| Not Available |
| Full Name | Mrs Allison Marie Curtis |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 22 Years |
| Location | 65 N Madison Ave, Pasadena, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083808703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 557547 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huntington Memorial Hospital | Pasadena, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Huntington Medical Foundation | 4587631601 | 72 |
News Archive
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.
The U.S. Food and Drug Administration today issued draft updated recommendations to help manufacturers determine when they are required to notify the FDA about modifications made to certain medical devices already on the market, including a separate guidance applicable to software devices.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
Cornerstones Health Inc., a nonprofit organization working to improve communication between patients with inflammatory bowel disease (IBD) and physicians who treat IBD, in collaboration with Imedex, LLC and Mechanisms in Medicine Inc., announced the launch of the new YouTube "You and IBD" - Animated IBD Patient Channel.
Strong communication skills are essential for preparing scientific articles, grant proposals, posters, and slide presentations. However, these skills are not commonly taught in schools of public health, medicine, or allied health sciences.
› Verified 9 days ago
| Entity Name | The Huntington Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154467181 PECOS PAC ID: 4587631601 Enrollment ID: O20040923000968 |
News Archive
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.
The U.S. Food and Drug Administration today issued draft updated recommendations to help manufacturers determine when they are required to notify the FDA about modifications made to certain medical devices already on the market, including a separate guidance applicable to software devices.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
Cornerstones Health Inc., a nonprofit organization working to improve communication between patients with inflammatory bowel disease (IBD) and physicians who treat IBD, in collaboration with Imedex, LLC and Mechanisms in Medicine Inc., announced the launch of the new YouTube "You and IBD" - Animated IBD Patient Channel.
Strong communication skills are essential for preparing scientific articles, grant proposals, posters, and slide presentations. However, these skills are not commonly taught in schools of public health, medicine, or allied health sciences.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Allison Marie Curtis, NP 526 Ranchito Rd, Monrovia, CA 91016-3732 Ph: (626) 305-0520 | Mrs Allison Marie Curtis, NP 65 N Madison Ave, Suite 800, Pasadena, CA 91101-2035 Ph: (626) 792-3141 |
News Archive
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.
The U.S. Food and Drug Administration today issued draft updated recommendations to help manufacturers determine when they are required to notify the FDA about modifications made to certain medical devices already on the market, including a separate guidance applicable to software devices.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.
Cornerstones Health Inc., a nonprofit organization working to improve communication between patients with inflammatory bowel disease (IBD) and physicians who treat IBD, in collaboration with Imedex, LLC and Mechanisms in Medicine Inc., announced the launch of the new YouTube "You and IBD" - Animated IBD Patient Channel.
Strong communication skills are essential for preparing scientific articles, grant proposals, posters, and slide presentations. However, these skills are not commonly taught in schools of public health, medicine, or allied health sciences.
› Verified 9 days ago
Ms. Jordan Meier, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3002 Margaret Dr, Pasadena, CA 91107 Phone: 818-383-5339 | |
Mrs. Jessica Alexandra Monzon, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Planned Parenthood, 1045 N Lake Ave, Pasadena, CA 91104 Phone: 626-798-0706 | |
Nwamaka Nwosu, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 117 E Colorado Blvd Ste 600, Pasadena, CA 91105 Phone: 844-735-1418 | |
Charlene Reed Frando, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2750 E Washington Blvd Ste 230, Pasadena, CA 91107 Phone: 626-296-8900 | |
Gina Joanne Digiovanni, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 351 S. Hudson, Suite Number 130, Pasadena, CA 91109 Phone: 626-795-6981 Fax: 626-578-1204 | |
Mrs. Margaret Lester, RNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 39 Congress St, Suite 301, Pasadena, CA 91105 Phone: 626-486-0181 | |
Ms. Deanna Lyn Sanchez, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 203 S Michillinda Ave, Pasadena, CA 91107 Phone: 626-405-8033 |